JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
Conditions
- Immune Checkpoint Inhibitor-Induced Dermatitis
Interventions
- DRUG: treated with JAK inhibitors orally for 28 days
Sponsor
Shixiu Wu